Tonix Pharma Gets IND Clearance To Begin Clinical Trials Of TNX-102 SL In Treatment Of Long COVID

Tonix Pharmaceuticals Holding Corp. (TNXP) announced FDA has cleared the Investigational New Drug application to support a phase 2 clinical trial with TNX-102 SL1 as a potential treatment for a subset of patients with Long COVID whose symptoms overlap with fibromyalgia. The phase 2 study will be a double-blind randomized, placebo-controlled 14-week trial to evaluate the safety and efficacy of sublingual TNX-102 SL 5.6 mg daily at bedtime in the treatment of patients with multi-site pain. There is currently no approved drug for the treatment of Long COVID.

The company said the trial will be conducted at approximately 30 sites to enroll approximately 470 patients who will be randomized in a 1:1 ratio to treatment with TNX-102 SL or placebo tablets.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission or FTC, has sued Walmart for allowing its money transfer services to be used by fraudsters, who fleeced consumers out of hundreds of millions of dollars. The retail giant is alleged to have looked the other way to pocket millions in fees while scammers took advantage of its failure to properly secure the money transfer services offered at Walmart stores. Home improvement retailer Bed Bath & Beyond, Inc. (BBBY) reported on Wednesday a net loss for first quarter that sharply widened from last year, hurt by hefty transient costs related to inventory markdown reserves and port-related supply chain fees. Both adjusted loss per share and net sales missed analysts' expectations. Tesla Inc. laid off about 200 employees in its Autopilot unit as the luxury electric car maker closed down its office in San Mateo, California as part of cost cutting efforts, reports said. The San Mateo office, where employees worked on improving the driver assistance systems, marketed as Autopilot, had about 350 employees before the cut.
Follow RTT